We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
REVLIMID lenalidomide 25mg capsule blister pack, Bristol-Myers Squibb Australia Pty Ltd, CON-1398
Product name
REVLIMID lenalidomide 25mg capsule blister pack
Sponsor name
Bristol-Myers Squibb Australia Pty Ltd
Batches
C003034
Consent start
Consent no.
CON-1398
Duration
The consent is effective from 13 August 2025 until 1 November 2026.
Standard
Paragraph 8(1)(i) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The products do not conform because the labels contain the contact details of
the previous sponsor (Celegene Pty Ltd) in place of the current sponsor
(Bristol-Myers Squibb Australia Pty Ltd ), following a transfer of the
sponsorship of the products.
Import, Supply, &/or Export
import and supply
Therapeutic product type
Prescription medicines